Movement Alert|ILUVATAR COREX Intraday Rise 3.04% in Regular Trading, performance and cost advantages of TianGai 300 remain in focus

Market Focus11-09

On November 9, ILUVATAR COREX rose 3.04% in Regular Trading, trading at HK$63.9, with turnover of HK$84.42 million.

The latest market-moving context points to continued investor attention on the company’s recently disclosed TianGai 300 test results. Public disclosures indicated that under a typical PD-separated deployment, normalized single-card end-to-end throughput reached 1.05 times that of an international mainstream top-tier GPU, while the IXL144 supernode could reduce cost per million effective tokens by about 40% versus mainstream international solutions.

Additional disclosed operating data also supported sentiment: chip shipments exceeded 80,000 units in the first ten months, and first-half revenue reached RMB945.7 million, up 191.6% year over year. The combination of product validation, cost efficiency and shipment growth has remained the main publicly visible backdrop for the stock’s recent activity.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment